A Study on a New Tetravalent Dengue Vaccine (TDV) Formulation in Healthy Adults
A Study on a New Tetravalent Dengue Vaccine (TDV) Formulation in Healthy Adults
Active, not recruiting · NCT07047521 · Registry updated 2026-07-17Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study on a New Tetravalent Dengue Vaccine (TDV) Formulation in Healthy Adults | Flaviviridae infectious disease, Flavivirus Infections, Infections, Mosquito-Borne Diseases, RNA Virus Infections, arbovirus infection, dengue disease, vector-borne disease, viral hemorrhagic fever, viral infectious disease | Active, not recruiting | Phase 3 | 2026-07-17 | NCT07047521 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Takeda | 163 |
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Emeritus Research Camberwell (Melbourne) | Camberwell | Australia | 1 |
| Emeritus Research Sydney | Botany | Australia | 11 |
| Paratus Clinical Research Central Coast | Kanwal | Australia | 4 |
| Paratus Clinical Research Western Sydney | Blacktown | Australia | 1 |
| Veritus Research | Bayswater | Australia | 15 |